Cloning by nuclear transfer remains inefficient, but is more efficient when nuclei from embryonic cells or embryonic stem cells (ECNT) are employed as compared with somatic cells (SCNT). The factors determining efficiency have not been elucidated. We find that somatic and embryonic nuclei differ in their ability to organize meiotic and mitotic spindles of normal molecular composition. Calmodulin, a component of meiotic and mitotic spindle chromosome complexes (SCCs), displays sharply reduced association with the SCC forming after SCNT, but not ECNT. This defect persists in mitotic spindles at least through the second mitosis, despite abundant calmodulin expression in the cell, and correlates with slow chromosome congression. We propose that somatic cell nuclei lack factors needed to direct normal SCC formation in oocytes and early embryos.
INTRODUCTION
The ability to produce genetically identical offspring by nuclear transfer has existed for about five decades. The advent of techniques for successful cloning using somatic cell nuclei from fetal or adult stages (SCNT) has given rise to the potential for many benefits in basic and applied research, as well as new clinical approaches. The combined data from both amphibian and mammalian nuclear transfer studies have yielded three general observations. First, cloning using somatic cell nuclei from fetal or adult stages is generally inefficient, typically in the range of 1-5% (Rhind et al., 2003) .
Second, reprogramming appears to be slow and incomplete, so that donor cell nuclei direct the expression of genes that are not normally expressed in the embryo, thereby giving cloned embryos characteristics different from those of normal embryos (Chung et al., 2002 (Chung et al., ,2003 Gao et al., 2003a; Latham, 2004; Ng and Gurdon, 2005) . Third, the efficiency of cloning declines with the advancement of developmental stage from which the donor nucleus is obtained (Tsunoda et al., 1987; First and Prather, 1991; DiBerardino, 1997; Rideout et al., 2000; Humpherys et al., 2002; Gao et al., 2003b; Latham, 2004,) .
Among amphibians, embryonic nuclei progressively lose developmental potential after the blastula stage (King and Briggs, 1955) . In mammals, it has been possible to produce multiple cloned offspring from the cells of a single preimplantation stage embryo using 2-cell blastomeres as recipients (Kono et al., 1991) , whereas this procedure does not produce offspring when somatic cell nuclei are employed. Moreover, a 10-20 fold greater rate of development from blastocyst to term is seen for ECNT embryos prepared with embryonic stem (ES) cell nuclei as compared with SCNT embryos (Rideout et al., 2000; Eggan et al., 2001; Humpherys et al., 2002; Gao et al., 2003b ).
These observations are most often attributed to effects of chromatin structure, and how that chromatin structure changes during development of donor cell lineages. The establishment of stable, transcriptionally active or inactive chromatin configurations could inhibit reprogramming. Such chromatin structures may become increasingly prevalent with developmental stage and during cellular differentiation. One example of this is seen with X chromosome regulation, which is indeed defective in mouse SCNT embryos, particularly for genes near Xist, suggesting that the stable heterochromatic state of the inactive X chromosome is difficult to disrupt (Nolen et al., 2005) .
Parameters other than chromatin structure and gene reprogramming may also influence cloning outcome. In mammals, most cloning studies are performed using mature metaphase II stage ovulated oocytes as recipients. The normal substrate for the ooplasm is the incoming sperm nucleus, which the oocyte must merge with its own chromosomes to create a totipotent embryonic genome. During this process, the sperm DNA must be stripped of protamines, repackaged with histones, interact with the ooplasm to form a pronucleus, undergo DNA replication and repair, and then participate successfully in the process of mitosis. Cloning requires that the oocyte act upon a different substrate than it would normally, and thus that this alternative substrate (the donor nucleus) recapitulate all of these processes as closely as possible. Defects in any of these processes could seriously compromise development.
The first step in the cloning procedure is removal of the meiotic spindle chromosome complex (SCC) from the recipient oocyte, in order to remove the oocyte chromosomes. The removal of the SCC may deprive the cloned constructs of essential factors. Cloned rhesus monkey embryos made with somatic cell nuclei display deficiencies in the association of several proteins (HSET, EG5, NuMA) with the spindle chromosome complex (SCC) that forms after nuclear transfer (Simerly et al., 2003) . This led to the suggestion that primate clones may experience mitotic defects, preventing cloning (Simerly et al., 2003) . Defects in SCC formation following SCNT could compromise successful mitotic division and thus compromise the genomic integrity of cloned embryos. This problem may not be unique to primate cloning, as an increased incidence of aneuploidy/polyploidy has been reported for cloned embryos in several species (Booth et al., 2003; Shi et al., 2004; Nolen et al., 2005) . It can be noted, however, that the SCC contains many essential proteins with many different activities, that only a few proteins have been examined in SCNT constructs, and that the degree of depletion after SCC removal has not been examined by quantitative means.
Interestingly, some of the proteins believed to be depleted from the rhesus oocyte by SCC removal actually persist in the ooplasm, but appear unable to assemble onto spindles correctly after SCNT (Simerly et al., 2003) . In addition, cloned rhesus embryos produced using embryonic nuclei (ECNT) can develop to fetal stages and birth (Meng et al., 1997; Mitalipov et al., 2002) , again indicating a significant effect of nuclear donor developmental stage. These observations raise the possibility that the defects in SCC formation observed after SCNT in rhesus monkey may reflect deficiencies in the interaction of somatic cell nuclei with the ooplasm, which might be shared with SCNT in other species. Moreover, such observations raise the possibility that the differences in success of SCNT and ECNT may be partly attributable to differences in the interactions of these nuclei with the ooplasm, such as differences in the SCC formation and function.
To investigate these possibilities, we examined in mouse cloned constructs the effects of SCC removal on SCC-associated protein content, assembly of these proteins onto the newly formed pseudo-meiotic SCC, their association with the first mitotic SCC, and the relative effects of employing donor nuclei from somatic cells versus embryonic cells on SCC composition. We find that somatic and embryonic nuclei differ in their abilities to direct the formation of SCC with correct molecular compositions. This reveals a novel interaction between nucleus and ooplasm that controls SCC formation in a nucleus origin-dependent manner. The possible significance of this to SCNT biology is discussed.
MATERIALS AND METHODS

Cloning and Embryo Culture
Ovulated oocytes were obtained from adult (B6D2)F 1 females 8-12 weeks of age by superovulation as described (Chung et al., 2002 (Chung et al., , 2003 Gao et al., 2003a Gao et al., , 2004a .
Adherent cumulus cells were removed by hyaluronidase treatment (120 IU/ml, SigmaAldrich, St. Louis, MO) and the oocytes were cultured in CZB medium supplemented with glucose (Chung et al., 2002) . Adult SCNT was performed as described (Chung et al., 2002 (Chung et al., , 2003 Gao et al., 2003a Gao et al., , 2004a . Cloned constructs were cultured in minimal essential medium alpha formulation (MEMα) medium as described (Gao et al., 2004b 
RT-PCR Analysis
Quantitative RT-PCR was performed using the Quantitative Amplification and Dot Blotting (QADB) method as described (Rambhatla et al., 1995) . The quantitative aspects of this method have been documented and the method applied in numerous studies (reviewed, Zheng et al., 2004) . Between 3 and 6 samples of 8-10 embryos each were collected for each stage analyzed for the developmental time series. cDNA probes were produced by RT-PCR from ovary RNA. Primers employed to obtain the cDNAs are given in Table 1 . The identities of cDNA probes were confirmed by DNA sequencing.
Embryo Fixation and Confocal Microscopic Analysis
Mouse oocytes, embryos, clones and tetraploids were incubated for 2-3 min in acidic tyrode solution (pH 2.5-2.7; Sigma, St. Louis, MO) to remove the zona pellucida, were measured, and compared to the mean intensity of the entire remaining ooplasm, to calculate the SCC:ooplasm ratio. This permitted comparisons of ratios between different planes of focus, and between different constructs. Measurements were performed on a minimum of three separate constructs, and the mean ratios calculated. Mouse fetal fibroblasts were cultured on glass slides, and then fixed and processed as described above. To obtain M-phase fibroblasts, cultures were treated for 6 h with 50 ng/ml nocadazole (Sigma).
Western Blot Analysis
After collection, embryos, clones, MII stage oocytes, and ooplasts were rapidly washed with ice-chilled PBS. After addition of 2x Laemmli's buffer (Laemmli, 1970) and heating for 5 min at 100 0 C, lysates prepared from 100 oocytes/embryos of each stage were subjected to SDS-PAGE electrophoresis in 15% polyacrylamide gels (29/1; Biorad Laboratories, Hercules, CA) and blotted onto a hydrophobic polyvinylidene difluoride (PVDF) transfer membrane (Amersham Biosciences, Piscataway, NJ) for 1 h at 50 V.
The membrane was blocked with Tris buffered saline (TBS; 20 mM Tris-HCl, pH 7.6, 137 mM NaCl, 0.05% Tween-20) containing 5% nonfat dry milk for 1 h at room temperature. Incubations with mouse anti-calmodulin (1:500), mouse anti-PLK1
(1:1000), or rabbit anti-TCTP (1:1000) were performed overnight at 4 0 C; this was followed by 1 h incubation in a horseradish peroxidase-conjugated anti-mouse or antirabbit (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA), and enhanced chemiluminescent detection (Supersignal Pierce, Rockford, IL). The Western blot experiments were repeated three times. For quantitation, scanned images were evaluated using the Fuji Photo Film Co. Image Guage 4.0 program (Fujifilm Medical Systems, U.S.A.). Average ratios were calculated from three independent measurements and the standard error of mean calculated (except for cytoplast, where only two measurements were obtained).
RESULTS
Our objective in this study was to evaluate the consequences of SCC removal and cloning on subsequent SCC formation, both before oocyte activation and as the cloned constructs progress into the early mitotic divisions. We employed a combination of Western blotting and indirect immunofluorescence to examine SCC formation and composition during this series of events.
Effects of SCC removal on oocyte composition
To determine whether SCC removal might deplete the oocyte of SCC-associated proteins, and thereby affect SCC formation, we first examined the effects of SCC removal on calmodulin content. Calmodulin is a key transducer of intracellular signals and a regulator of cellular and genetic functions. While most widely thought of as a cytoplasmic or membrane-associated signaling molecule, calmodulin associates with both meiotic and mitotic SCC, and calmodulin-dependent proteins play key roles in both mitosis and meiosis (Welsh et al., 1979; Sun et al., 1992; Moser et al., 1997; Johnson et al., 1998; Yin et al., 1998; Elliott et al., 1999; Li et al., 1999; Stirling and Stark, 2000; Cyert, 2001; Gonczy et al., 2001; Moisoi et al., 2002; Takahashi et al., 2002; Su and Eppig, 2002; Fan et al., 2003; Flory et al., 2003; Yu et al., 2004; Muller et al., 2005; Holmfeldt et al., 2005; Yoder et al., 2005) .
Western blot analysis (Fig. 1A) revealed that SCC removal led to a partial depletion of calmodulin content to 34% of the starting value for intact MII stage oocytes.
By 1 h after SCC removal, much of the calmodulin content appeared to have recovered in both ooplasts and SCNT constructs (not activated). For ooplasts, which did not receive nuclei and were incubated for 1 h post-SCC, we observed ooplast:MII oocyte ratios of 0.69. 0.83, and 1.41 (average 99+23% of the original MII stage oocyte value), indicating an ability of the ooplasts to restore calmodulin expression in all three experiments . In all three experiments, calmodulin content in ooplasts then declined slightly between 1 and 3 h post-SCC, falling to an average value of 66+23% of the MII stage. This decline between 1h and 3h may reflect a reduced rate of calmodulin synthesis, enhanced rate of calmodulin degradation, or both, as time progresses without oocyte activation. In SCNT constructs, calmodulin content was still slightly reduced at 1 h post-SCNT (77+19% of MII value, total elapsed time is 2h post-SCC removal), but then in contrast to 3h ooplasts, continued to increase, recovering to 90+16% of the MII stage level by 3h post-SCNT (4 h post-SCC removal). Thus, although SCC removal initially reduced total calmodulin content of the cell, the ooplasts and SCNT constructs were nevertheless able to restore a substantial amount of what was lost by SCC removal, and this proceeded more efficiently in SCNT constructs than in ooplasts. In all three experiments, calmodulin persisted at a high level through the late 1-cell stage in SCNT embryos, although its abundance was consistently lower than that in MII oocytes and fertilized late 1-cell stage embryos (75+5% and 68+6%, respectively) (Fig. 1A) . Consistent with the recovery of calmodulin content following SCC removal and after SCNT, maternally-derived expression of calmodulin types 1, 2, and 3 mRNAs was observed in the murine oocyte and early embryo (Fig. 1B) . The three calmodulin mRNAs displayed different temporal patterns of expression during subsequent cleavage development in fertilized embryos, with the calmodulin 1 and 2 mRNAs being expressed more highly at early stages, and the calmodulin 3 mRNA being upregulated at later stages.
We also observed by Western blotting recovery of other SCC proteins after SCC removal, including PLK1, TCTP, HSET, EG5, RAN, Aurora A, GSKα, and GSKβ.
Western blot data for two of these proteins, Polo-like kinase 1 (PLK1) and translationally controlled tumor protein (TCTP), are shown as examples (Fig. 1A) . There was again a reduction in the apparent amount of TCTP and PLK1 present after SCC removal. Both proteins recovered partially in abundance by 3 h post-SCC removal and by 1 or 3 h post SCNT (equivalent to 2 or 4 h post-SCC removal, respectively), and both proteins were fully replenished in abundance by the late 1-cell stage (Fig. 1A, compare lanes 7 and 8) .
Thus, all SCC proteins examined thus far can be restored either partially or entirely in abundance following SCC removal.
Deficient assembly of calmodulin onto the pseudo-meiotic spindle following SCNT
Although Western blotting revealed substantial expression of calmodulin in the SCNT constructs, immunocytochemistry and confocal imaging revealed that calmodulin association with the pmSCC was greatly reduced at both 1 and 3 h post-SCNT in the vast majority of diploid constructs prepared with cumulus cell nuclei ( Fig. 2A) . The same result was obtained using 14 day fetal fibroblasts as nuclear donors (Fig. 3B ), indicating that this result was not unique to cumulus cell nuclei. A small proportion of SCNT embryos displayed significant calmodulin association with the pmSCC at 3 h post-SCNT, but these were not observed at the late 1-cell stage, indicating that this association was likely not stable (Fig. 2B) . Examination of tetraploid SCNT embryos (produced by performing SCNT without SCC removal) revealed that calmodulin association with the pmSCC was also reduced even when the oocyte (oo)SCC was not removed (Fig. 4,   columns 1 and 2 ). The clear difference between the ooSCC (distinguishable by position and tightly packed chromosomes) and pmSCC (characterized by more loosely packed chromosomes) within the same cell illustrates the calmodulin deficiency in the pmSCC formed after SCNT. Quantitative image analysis revealed that the intensity of calmodulin staining of the pmSCC at 1 h post-NT in tetraploid constructs prepared with cumulus cell nuclei was only 20% above the intensity of the surrounding ooplasm, whereas the intensity of ooSCC staining was nearly 3 times the value of the surrounding ooplasm, indicating a nearly ten-fold lower enrichment of calmodulin in the pmSCC than in the ooSCC. By contrast, staining intensities for two other spindle-associated proteins, PLK1
and TCTP (Tong et al., 2002; Yarm, 2002) were each only ~25-30% greater in the ooSCC than the pmSCC, confirming the specificity of the effect for calmodulin. It may be noted that for tetraploid embryos the ooSCC and pmSCC often merged into a single SCC by 3h post-SCNT. For a minority of constructs in which the two SCCs remained separate, a slight recovery in calmodulin association with the pmSCC was evident by 3h post-SCNT, but this did not attain an intensity comparable to that seen with the ooSCC.
Thus, even within the same ooplasm, the ooSCC differs compositionally from the pmSCC with respect to calmodulin association.
The defect observed with calmodulin localization to the pmSCC of SCNT embryos is not indicative of a generalized failure of a spindle to form. The SCC in fact forms, and in addition to PLK1 and TCTP (Figs. 2 and 4) , we also observed apparently normal association of β-tubulin, NuMA, ATRX, Aurora A, RAN, HSET, EG5, and kendrin with the pmSCC of SCNT embryos (not shown). The efficient association of these proteins with the pmSCC indicates that the SCCs assemble in these oocytes, and that a majority of proteins associates with the SCC as expected.
Published studies revealed calmodulin association with the SCC of M phase somatic cells (Welsh et al., 1979; Li et al., 1999; Yu et al., 2004) . Nevertheless, to address further the possibility that the failure to see calmodulin association with the pmSCC in cloned constructs was related to an inability of calmodulin to associate with somatic cell mitotic SCCs, we examined calmodulin expression in cultures of proliferating untreated and nocadazole-treated fibroblasts (because cumulus cell donors were not cultured and were not in M phase, these cells were not examined) (Fig. 5) . We observed that in the fibroblasts, calmodulin was expressed throughout the cell cycle, and was associated with the SCC as seen in published studies for fibroblasts and other cell types (Welsh et al., 1979; Li et al., 1999; Yu et al., 2004) . Western blot analysis also revealed calmodulin expression in cumulus cells and 3T3 cells (data not shown). Thus, neither a lack of calmodulin expression nor a lack of association with the SCC in the somatic cells can account for the observed lack of calmodulin association with the pmSCC in SCNT embryos.
Calmodulin association with the SCC following ECNT
In contrast to results obtained with SCNT embryos, diploid cloned ECNT constructs prepared with embryonic blastomere nuclei (Fig. 3C ) or embryonic stem cell nuclei (Fig 3D) displayed abundant calmodulin association with the pmSCC. Cloned tetraploid constructs made with early eight-cell stage embryonic nuclei displayed strong calmodulin association with both the ooSCC and the pmSCC at 1h and 3h post-SCNT (Fig. 4, columns 3-6 ), further indicating a difference between ECNT and SCNT. This occurred when nuclei were introduced by either electrofusion or piezo-assisted microinjection (method identical to that employed for adult cumulus cell nuclei). Image analysis revealed that the accumulations of calmodulin on the pmSCC and ooSCC were nearly equal, differing by only ~7% at 1 h post-NT, and that PLK1 and TCTP again displayed very similar accumulations between the ooSCC and pmSCC. These results, combined with the Western blot data, further indicate that the deficiency of calmodulin association following SCNT was not a result of depletion of the protein from the ooplasm, but rather a specific deficiency related to the somatic cell origin of the donor nucleus.
No apparent differences in cytoplasmic localization of calmodulin were observed in our analyses (Fig. 2) , and the diffuse cytoplasmic distribution observed here for MII stage oocytes and one-cell embryos was similar to that shown previously for MI and anaphase stage pig oocytes (Fan et al., 2003) and early mouse embryos (Sobel et al., 1998) . Thus, the difference observed between ECNT and SCNT indicates an effect on calmodulin association specifically with the SCC.
Continued deficiency of SCC-associated calmodulin at the first and second mitosis
Absence of calmodulin from the pmSCC might be of no consequence, because the cloning procedure routinely involves suppression of polar body extrusion, thus preventing any loss of chromosomes during oocyte activation. Only defects in the mitotic spindles forming during cleavage should produce genetic defects. Examination of SCNT embryos revealed that calmodulin remained largely absent from the first mitotic SCC in late one-cell SCNT embryos (Fig. 2) . Similarly, at the late two-cell stage we again observed a calmodulin deficiency on the spindle at the second mitosis of a majority (13 of 14 examined, 93%) of SCNT embryos (Fig. 6) . Thus, the molecular defects responsible for reduced calmodulin association with the pmSCC continue in a majority of embryos at least through the second mitotic division. Unlike calmodulin, PLK1 and TCTP were associated abundantly with the first mitotic spindle (Fig. 2) . In contrast, to embryos obtained by SCNT, calmodulin associated efficiently with the mitotic SCC of late 1-cell embryos prepared by ECNT (Fig 3E) , indicating once again a difference between SCNT and ECNT.
Chromosome congression in cloned constructs
The foregoing observations indicated that the differences between ECNT and SCNT embryos with respect to calmodulin association with the SCC persisted at least into the second mitosis. A deficiency of SCC formation could lead to defects in assembly of chromosomes onto the spindle after SCNT. It is thus noteworthy that the pmSCC formed following ECNT consistently displayed much greater congression of chromosomes on the metaphase plate than the pmSCC formed with SCNT, in both diploid and tetraploid constructs (Figs. 3 and 4) . We also observed lagging chromosomes at the first and second mitotic divisions (Figs. 2 and 6 ). These observations indicate some impairment of chromosome attachment to the spindle following SCNT, but this was not observed with ECNT.
DISCUSSION
The data presented here reveal a striking interaction between nucleus and ooplasm that affects SCC formation and composition. This interaction is donor cell typedependent, indicating that factors associated with nuclei from different cell types can direct the formation of qualitatively different SCC. The data also reveal for the first time a specific molecular difference that may help to explain both the low efficiency of SCNT, and the stage-dependent restriction in success that distinguishes ECNT from SCNT.
The differential effects of SCNT and ECNT on SCC composition persist in a majority of embryos at least until the second mitosis, and could thus affect genome stability. We note that SCNT embryos display a deficiency in the timely congression of chromosomes to the metaphase II plate and also a delay in chromosome congression at the first and second mitosis. These defects were not observed in ECNT embryos. It is intriguing that enhanced calmodulin association with the pmSCC in ECNT embryos relative to SCNT embryos correlates with improved congression of chromosomes, and with the 10-20 fold greater success of term development reported for ECNT blastocysts (Rideout et al., 2000; Eggan et al., 2001; Humpherys et al., 2002; Gao et al., 2003b) .
Defining the specific roles of calmodulin in spindle formation and function remains an active and dynamic area of study. Published studies from a variety of organisms indicate that calmodulin-binding proteins may regulate multiple process during meiosis and mitosis, including microtubule nucleation and spindle formation, spindle positioning, progression from metaphase to anaphase, correct timing of separation of homologues and chromatids, and regulation of cleavage furrow formation (Johnson et al., 1998; Elliott et al., 1999; Stirling and Stark, 2000; Cyert 2001; Gonczy et al., 2001; Su and Eppig, 2002; Fan et al., 2003; Holmfeldt et al., 2005; Yoder et al., 2005) . It is intriguing that SCNT embryos, despite the substantial reduction in calmodulin association with the SCC, nevertheless undergo cleavage. This suggests that other proteins may substitute at least partially for calmodulin, and indeed other calmodulinrelated, calcium-binding proteins (e.g., centrin) exist on spindles (Hu et al., 2004) .
Interestingly, oocytes treated with diazepam (a calmodulin inhibitor) display meiotic delay and aneuploidy, but can nevertheless progress through meiotic divisions (Yin et al., 1998 ). While such inhibitor-based studies are complicated by the need to discriminate between effects on cytoplasmic versus SCC-associated calmodulin, such results indicate that the observed calmodulin deficiency on the SCC in SCNT embryos may not be expected to cause an obligate arrest, but rather may predispose SCNT embryos to mitotic defects. Accordingly, karyotype analyses have revealed a dramatically increased incidence of aneuploidy/polyploidy (75% or more of embryos, and 10% or more of cells) in SCNT blastocysts, but these embryos nevertheless contain a significant proportion of euploid cells (Booth et al., 2003; Shi et al., 2004; Nolen et al., 2005) . Thus, mitotic errors indeed appear to occur at increased rates in SCNT embryos, but such errors likely arise on a stochastic basis during any cleavage division. The observed persistence of calmodulin deficiency through at least the first two mitoses in a majority of SCNT embryos supports a model in which molecular deficiencies in the mitotic SCC of SCNT embryos predisposes the individual blastomeres of these embryos to an increased risk of mitotic errors at each cleavage division.
How can one explain an effect of nuclear origin on spindle formation and composition? One possibility is that donor cell centrioles differ between embryonic and somatic cells. Because both ES and somatic cells possess typical centrioles (Sathananthan et al., 2002; Baharvand and Matthei, 2003) , however, this explanation seems unlikely to account for the differences in SCC formation. Another possibility is that, just as chromatin structure affects gene transcription, it also affects SCC formation.
Although mouse oocytes can form spindles without chromatin (Brunet et al., 1998; Woods et al., 1999) , chromatin plays an essential organizing role by harnessing the innate spindle forming potential of the oocyte and stabilizing the spindle (Brunet et al., 1998) .
We propose that the oocyte chromatin is endowed with one or more specific factors that direct correct spindle formation, and that this represents a specific requirement of spindle formation within the ooplasm. The mRNAs for these factors are likely absent from the mature oocyte, so that SCC removal irreversibly depletes the ooplasm of these proteins.
These factors are likewise present on the chromatin of embryonic nuclei, which must express the corresponding genes, given the ability of ES cell nuclei to behave similarly to blastomere nuclei. As development progresses, and somatic cell characteristics diverge progressively from embryonic cell characteristics, these factors become dispensable, and somatic cell nuclei no longer possess or require these factors for mitosis. Our observations are consistent with the hypothesis that somatic cell nuclei lack factors that are needed in the oocyte for efficient calmodulin association with the SCC.
A possible difference in the timing of post-nuclear transfer events with ECNT versus SCNT should be considered. The pace of histone H1 transitions can vary in a subtle manner with different donor cell types (Becker et al., 2005) . For example, SCNT with cumulus cell nuclei and myoblast nuclei is followed by an immediate binding of the oocyte specific histone H1 variant H1FOO, and then complete removal of detectable somatic type H1 by 1 h after SCNT. Following SCNT with fetal fibroblasts or ECNT with ES cell nuclei, immediate binding of H1FOO is again observed, along with rapid depletion of somatic H1, but a low level of somatic H1 can persist for slightly longer, being completely removed within 3 h (Gao et al., 2004a; Teranishi et al., 2004) . It is thus important to note that the subtle difference observed for removal of the last vestige of somatic H1 after nuclear transfer does not follow a clear delineation between somatic and embryonic donor cell types, and thus does not follow the same pattern observed here, wherein a clear distinction between ECNT and SCNT is observed for calmodulin binding in the SCC.
We examined the presence and pmSCC association of two proteins that could be related to calmodulin localization (kendrin, TCTP), and neither appeared depleted or absent. Thus, the identity of the depleted factor(s) remains unknown. Specific chromatin-associated proteins, centromeric proteins, or kinetochore proteins (Dogterom et al., 1996; Heald, 1996; Maiato and Sunkel, 2004; Sullivan and Karpen, 2004; Varmark, 2004; ) The failure of calmodulin to recover entirely in abundance following SCC removal, its slight diminishment between 1 and 3 h post-SCC removal in ooplasts, and its failure to recover completely by the late one-cell stage indicate that calmodulin content in the oocyte and early embryo is likely limited by protein stability. We have noted previously that a delay in activation of cloned constructs compromises viability, and that treatment of cloned constructs with the proteasome inhibitor, MG132, overcomes this effect of delayed activation . The protective effect of MG132 may thus be partly due to promoting the recovery of proteins like calmodulin that are partially depleted by SCC removal and that are difficult to replenish due to limited stability. It is also interesting to note that the rate of decline in calmodulin content appeared to be less in SCNT embryos than in ooplasts, as 3h SCNT embryos contained about 66% more calmodulin than 3h ooplasts. This indicates that the presence of chromosomes within the oocyte may affect protein stability, possibly by facilitating pmSCC formation.
SCNT in the rhesus monkey can deplete the oocyte of some proteins (Simerly et al., 2003 (Simerly et al., , 2004 . Our data reveal an initial depletion of calmodulin and other proteins, followed by substantial recovery of abundance within hours of SCC removal. The proteins we examined include essential regulatory proteins such as PLK1, a regulator of spindle assembly and TCTP function (Tong et al., 2002; Yarm et al., 2002) . These data thus indicate that SCC removal likely does not lead to permanent depletion of a majority of essential SCC-associated proteins. Long-term and extensive depletion of proteins by SCC removal would likely require that such proteins be encoded by mRNAs that are absent from the maternal mRNA pool or otherwise not translatable within the oocyte, which would preclude these proteins from being restored soon after SCC removal.
Additionally, in order for SCC removal to deplete SCC-associated proteins from the whole oocyte significantly, such proteins would have to be very highly partitioned to the SCC, with little or no exchange to the ooplasmic compartment. While the aforementioned results indicate that, for most proteins, this does not occur during mouse cloning, the failure of calmodulin to associate with the SCC indicates that SCC removal must result in a permanent depletion of one or more proteins responsible for this localization. This indicates that SCC deficiencies such as those observed with primate cloning (Simerly et al., 2003 (Simerly et al., , 2004 are not unique to primates.
Cloning by SCNT with non-human primates appears to be more difficult as compared to other mammals, a result that may relate to depletion of SCC proteins and subsequent aneuploidy (Simerly et al., 2003 (Simerly et al., , 2004 . The development of cloned rhesus monkeys to advanced stages of pregnancy or to birth (Meng et al., 1997; Mitalipov et al., 2002) and the establishment of pregnancies in long-tailed macaques (Ng et al., 2004) indicate that mitotic errors may not pose an absolute barrier to cloning in primates.
Additionally, the first human embryonic stem cells (ESCs) derived from a cloned human embryo were euploid , further suggesting that at least some primate cloned constructs can complete cleavage development without mitotic errors. Our data indicate that cloning in both primate and non-primate species may be subject to an increased risk of mitotic errors related to depletion of SCC-associated proteins, and a deficiency of proteins specifically in somatic cell nuclei. Do our results imply that an improvement in cloning efficiency will be impossible? To the contrary, the results presented here point to a new direction of study that will help us to understand some of the molecular barriers to successful cloning. Restoring the ability to form an SCC of normal composition could provide one avenue for improving the cloning process, together with other strategies to address other deficiencies in the cloning process.
Additionally, such studies could shed new light on the roles of SCC-associated proteins in the normal embryo. 
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